Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Urelumab
Trade Name
Synonyms BMS-663513|BMS663513|BMS 663513
Drug Descriptions

Urelumab (BMS-663513) is an activating monoclonal antibody that targets CD137, resulting in activation of CD137-expressing immune cells, thereby enhancing T-cell mediated response to tumor cells (PMID: 31143521, PMID: 32052473).

DrugClasses TNFRSF9 Antibody 17
CAS Registry Number 934823-49-1
NCIT ID C62449


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cetuximab + Urelumab Cetuximab Urelumab 0 1
Nivolumab + Urelumab Nivolumab Urelumab 0 5
Relatlimab + Urelumab Relatlimab Urelumab 0 0
Rituximab + Urelumab Rituximab Urelumab 0 0
Urelumab Urelumab 0 4

Additional content available in CKB BOOST